Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Trends in Pharmacological Sciences|July 11, 2006
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular functionVassilios Papadopoulos, Mario Baraldi, Tomás R Guilarte, et al.Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.The International Journal on Drug Policy|February 21, 2018
A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulationOle Rogeberg, Daniel Bergsvik, Lawrence D Phillips, et al.Regulatory Toxicology and Pharmacology : RTP|September 19, 2015
Ranking the harm of non-medically used prescription opioids in the UKJan van Amsterdam, Lawrence Phillips, Graeme Henderson, et al.Frontiers in Pharmacology|April 18, 2022
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for DepressionRoberta Murphy, Hannes Kettner, Rick Zeifman, et al.Frontiers in Pharmacology|November 20, 2018
Predicting Responses to Psychedelics: A Prospective StudyEline C H M Haijen, Mendel Kaelen, Leor Roseman, et al.The British Journal of Psychiatry : the Journal of Mental Science|January 26, 2011
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trialGlyn Lewis, Jean Mulligan, Nicola Wiles, et al.Journal of Psychopharmacology (Oxford, England)|January 7, 2021
Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging studyAbhishekh H Ashok, Jim Myers, Gary Frost, et al.Network Neuroscience (Cambridge, Mass.)|May 27, 2024
Effects of classic psychedelic drugs on turbulent signatures in brain dynamicsJosephine Cruzat, Yonatan Sanz Perl, Anira Escrichs, et al.Public Health Genomics|May 31, 2016
Gene-Tailored Treatments for Brain Disorders: Challenges and OpportunitiesGiovanni Esposito, Jean Marc Burgunder, John Dunlop, et al.Pageof 19